The Payer Exchange
Unscripted conversations with the people shaping drug pricing, access, and reimbursement around the world.
Hosted by Omar Ali, Head of Payers at Verpora, The Payer Exchange brings you honest, off-the-record discussions with payers working at the frontline of healthcare funding. Each episode features a one-to-one conversation with a payer from a different country—exploring local challenges, emerging trends, and contrasting approaches to some of the biggest questions in market access.
From horizon scanning to contracting, rare disease to real-world evidence, we ask the same core questions—but get different answers every time.
This isn’t a panel. It’s not a pitch. It’s a rare chance to hear what really drives decision-making—direct from those making the decisions.
The Payer Exchange
Series 2 Trailer
What happens when the world’s pricing pressures start reshaping national systems from the inside?
In Season 2 of The Payer Exchange, we speak to former payers and policy leaders from five different countries—each responding to the same global trends in very different ways.
From MFN spillover to combination oncology, from HTA reform to value-based agreements, we look at how systems are adapting, what’s working, and where the pressure is still building.
Guests this season include:
🇬🇧 Yousaf Ahmed (UK)
🇵🇱 Krzysztof Łanda (Poland)
🇨🇦 Don Husereau (Canada)
🇧🇪 Lieven Annemans (Belgium)
🇸🇦 Abdulrazag Aljazairi (Saudi Arabia)
Each episode is a one-to-one conversation with someone who has made the difficult decisions on pricing, access, and funding. These are unfiltered discussions based on real experience inside the system.
Global voices. Local insight. Clear thinking on the future of market access.
Disclaimer: This podcast is for educational and informational purposes only, and is not intended as legal or policy advice. All content is based on non-confidential intelligence. Views expressed by the speakers are personal opinions and should not be attributed to anyone else. No part of this presentation may be reproduced for commercial purposes without the express permission of Omar Ali, Verpora Limited.
